Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 090032

Expand all

TELMISARTAN (TELMISARTAN)
20MG
Marketing Status: Prescription

Active Ingredient: TELMISARTAN
Proprietary Name: TELMISARTAN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090032
Product Number: 001
Approval Date: Jul 7, 2014
Applicant Holder Full Name: GLENMARK PHARMACEUTICALS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

TELMISARTAN (TELMISARTAN)
40MG
Marketing Status: Prescription

Active Ingredient: TELMISARTAN
Proprietary Name: TELMISARTAN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 40MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090032
Product Number: 002
Approval Date: Jul 7, 2014
Applicant Holder Full Name: GLENMARK PHARMACEUTICALS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

TELMISARTAN (TELMISARTAN)
80MG
Marketing Status: Prescription

Active Ingredient: TELMISARTAN
Proprietary Name: TELMISARTAN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 80MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090032
Product Number: 003
Approval Date: Jul 7, 2014
Applicant Holder Full Name: GLENMARK PHARMACEUTICALS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information